Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · Ministry or any other national or federal authority, including their regional or local subdivisions
- Value
- £2 across 2 lots
- Procedure
- Open procedure
- Sector
- Medical equipment & pharmaceuticals · Vaccines (CPV 33651600)
- Region
- London
- Official notice
- 052305-2025 on Find a Tender
- Timeline
-
- Contract date7 Aug 2025
- Published29 Aug 2025Published 22 days after the contract date
Description
Contracts for the supply of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme.<br/><br/>Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.<br/><br/>The awarding of lots is not appropriate for this procurement. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
Lots in this award
| Lot | Supplier | Value |
|---|---|---|
| Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025) | Merck Sharp & Dohme UK Ltd | £1 |
| Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025) | Glaxosmithkline UK Limited | £1 |
About the suppliers
Merck Sharp & Dohme UK Ltd: every public contract they have won, plus their Companies House record (company 00233687).
Glaxosmithkline UK Limited: every public contract they have won, plus their Companies House record (company 04310159).